Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Fodero-Tavoletti, Michelle T.a; b; c | Villemagne, Victor L.a; c; d; * | Paterson, Brett M.b; e | White, Anthony R.a; c; f | Li, Qiao-Xina; c | Camakaris, Jamesg | O'Keefe, Graemed | Cappai, Robertoa; b | Barnham, Kevin J.a; b; c | Donnelly, Paul S.b; e; *
Affiliations: [a] Department of Pathology, University of Melbourne, Victoria, Australia | [b] Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Victoria, Australia | [c] The Mental Health Research Institute, Parkville, Melbourne, Victoria, Australia | [d] Department of Nuclear Medicine, Centre for PET, Austin Health, Heidelberg, Victoria, Australia | [e] School of Chemistry, University of Melbourne, Victoria, Australia | [f] Centre for Neuroscience, The University of Melbourne, Victoria, Australia | [g] Department of Genetics, University of Melbourne, Victoria, Australia
Correspondence: [*] Correspondences to: Victor L. Villemagne, Department of Nuclear Medicine, Centre for PET, Austin Health, Studley Road, Heidelberg, Victoria, Australia, 3010. E-mail: villemagne@petnm.unimelb.edu.au. Paul S. Donnelly, School of Chemistry, University of Melbourne, Victoria, Australia, 3010. E-mail: pauld@unimelb.edu.au.
Abstract: A bis (thiosemicarbazonato) complex radiolabeled with positron emitting Cu-64 can be used for a new and alternative method for the non-invasive diagnosis of Alzheimer's disease using positron emission tomography (PET). Most imaging agents being investigated for the diagnosis of Alzheimer's disease target plaque burden but our new approach highlights altered copper homeostasis. This approach has the potential to offer complementary information to other diagnostic procedures that elucidate plaque burden.
Keywords: Alzheimer's disease, copper homeostasis, copper radiopharmaceuticals, diagnostic imaging, positron emission tomography (PET)
DOI: 10.3233/JAD-2010-1359
Journal: Journal of Alzheimer's Disease, vol. 20, no. 1, pp. 49-55, 2010
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl